MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
MIMEDX GROUP, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$4.38−0.05 (-1.13%)
Close on Oct 19, 2026
- Market cap
- $647.35M
- P/E (TTM)
- 109.5
- Dividend yield
- –
Share price
−$2.31 (−34.53%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
MIMEDX GROUP, INC. saw revenue fall 2.4% to $355.17M over the twelve months to Jun 30, 2026. Operating income fell 79.6% to $8.75M, moving the operating margin from 11.8% to 2.5%.
Revenue
$355.17M
-2.4% vs. a year earlier
Operating income
$8.75M
-79.6% vs. a year earlier
EPS, diluted
$0.04
-81.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $647.35M
- P/E ratio
- 109.5
- Price to sales
- 1.82
- Price to book
- 3.00
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $355.17M
- Net income
- $6.24M
- EPS, diluted
- $0.04
- Book value per share
- $1.46
- Diluted shares
- 148M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$355.17M-2.4% YoY
Gross profit
$280.05M-5.5% YoY
Operating income
$8.75M-79.6% YoY
Net income
$6.24M-80.6% YoY
EPS, diluted
$0.04-81.0% YoY
Free cash flow
–
Reported periodTrailing twelve months